Seasonal influenza vaccination: Progressing towards the EU’s 75% target Brussels
21.01.20 - 21.01.20
It has been 10 years since the EU Council adopted its 2009 Recommendation on Seasonal Influenza Vaccination, endorsing a 75% target vaccination rate for at risk and older age groups set by the World Health Organization (WHO).
Since then, some progress has been made. However, as stated in the EU State of Health Companion Report 2019, none of the EU Member States have reached the 75 % target for influenza vaccination coverage among older people and at risk groups. Moreover, the EU average vaccination coverage rate is just 43%, with several countries experiencing a dramatic decline. Challenges remain with increasing the influenza vaccination coverage rates within EU Member States for recommended vulnerable populations.
Please join us for a breakfast event on 21 January 2020 in the European Parliament to reflect on what has been achieved and what should be done to increase influenza vaccination coverage rates in the EU and protect European citizens. Influenza remains a serious, preventable and deadly disease which kills around 40,000 people per year in Europe. The event will also aim to identify how to join forces to minimise the impact of influenza, and improve control of influenza across Europe.
The event will be co-hosted by:
- MEP Dolors Montserrat (ES, EPP)
- MEP Sara Cerdas (PT, S&D)
This event will convene representatives from EU institutions, leading experts on the topic of influenza vaccination, as well as representatives of a broader health and citizens community.
Practical details:
Tuesday, 21 January 2020 from 08:00 to 10:00 (CET)
Room 6Q1
European Parliament, Brussels
Organised by Vaccines Europe
Vaccines Europe is a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA) and represents major innovative research-based vaccine companies. Companies represented within Vaccines Europe are involved in research and development (R&D), clinical trials, production and marketing of vaccines and are dedicated to improving public health through immunisation.
Practical details:
Tuesday, 21 January 2020 from 08:00 to 10:00 (CET)
Room 6Q1
European Parliament, Brussels
Organised by Vaccines Europe
Vaccines Europe is a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations (EFPIA) and represents major innovative research-based vaccine companies. Companies represented within Vaccines Europe are involved in research and development (R&D), clinical trials, production and marketing of vaccines and are dedicated to improving public health through immunisation.